Orexo AB (publ) (STO:ORX)
20.50
+0.66 (3.33%)
Jun 11, 2025, 2:55 PM CET
Orexo AB Employees
Orexo AB had 110 employees as of December 31, 2024. The number of employees decreased by 6 or -5.17% compared to the previous year.
Employees
110
Change (1Y)
-6
Growth (1Y)
-5.17%
Revenue / Employee
5.43M SEK
Profits / Employee
-1.91M SEK
Market Cap
684.58M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,806 |
Sectra AB | 1,249 |
Getinge AB | 11,791 |
Asker Healthcare Group AB | 4,030 |
Camurus AB | 256 |
Medicover AB | 47,256 |
AddLife AB | 2,181 |
Vimian Group AB | 1,200 |
Orexo AB News
- 9 days ago - Orexo to present clinical data for OX640 at the EAACI Congress - PRNewsWire
- 2 months ago - Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology - PRNewsWire
- 5 months ago - Orexo announces positive topline data from clinical study of OX640 in subjects with and without allergic rhinitis - PRNewsWire
- 6 months ago - Orexo, Abera to develop nasal powder vaccines based on AmorphOX technology - Seeking Alpha
- 6 months ago - Orexo enters into collaboration with Abera to develop nasal powder vaccines based on the AmorphOX technology - PRNewsWire
- 8 months ago - Orexo initiates new study of OX640 in participants with allergic rhinitis - PRNewsWire
- 8 months ago - Orexo AB reports Q3 results - Seeking Alpha
- 8 months ago - Orexo´s Nomination Committee for the Annual General Meeting 2025 - PRNewsWire